Additionally, Cox regression analysis revealed that ZNF300 hypermethylation was an independent prognostic factor affecting OS in both non-M3 AML and CN-AML patients (P = 0.013 and 0.018, respectively) (Table S9). This evidence concerns the gene ZNF300 and acute myeloid leukemia.